Excess mortality due to indirect health effects of the 2011 triple disaster in Fukushima, Japan: a retrospective observational studyTomohiro Morita, Masahiro Kami, Kenji Shibuya et al.|Journal of Epidemiology & Community Health|2017Cited by 63
Overview and transparency of non-research payments to healthcare organizations and healthcare professionals from pharmaceutical companies in Japan: Analysis of payment data in 2016Akihiko Ozaki, Tetsuya Tanimoto, Yurie Kobashi et al.|Health Policy|2020Cited by 59
Evaluation of Pharmaceutical Company Payments and Conflict of Interest Disclosures Among Oncology Clinical Practice Guideline Authors in JapanHiroaki Saito, Tetsuya Tanimoto, Akihiko Ozaki et al.|JAMA Network Open|2019Cited by 57
Pharmaceutical company payments to dermatology Clinical Practice Guideline authors in JapanAnju Murayama, Tetsuya Tanimoto, Akihiko Ozaki et al.|PLoS ONE|2020Cited by 45
Pharmaceutical payments to certified oncology specialists in Japan in 2016: a retrospective observational cross-sectional analysisAkihiko Ozaki, Tetsuya Tanimoto, Yosuke Onoue et al.|BMJ Open|2019Cited by 44